US Stock MarketDetailed Quotes

Altimmune (ALT)

Watchlist
  • 3.370
  • -0.010-0.30%
Close Apr 8 16:00 ET
  • 3.472
  • +0.102+3.02%
Post 20:01 ET
438.45MMarket Cap-3.37P/E (TTM)

Altimmune (ALT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
105.00%41K
420.00%26K
0.00%5K
0.00%5K
0.00%5K
-95.31%20K
-86.49%5K
-98.62%5K
-16.67%5K
-76.19%5K
Operating revenue
105.00%41K
420.00%26K
0.00%5K
0.00%5K
0.00%5K
-95.31%20K
-86.49%5K
-98.62%5K
-16.67%5K
-76.19%5K
Cost of revenue
Gross profit
Operating expense
-8.39%94.53M
16.28%28.92M
-15.78%20.86M
-14.29%22.93M
-18.58%21.82M
22.94%103.19M
17.09%24.87M
8.17%24.77M
48.50%26.75M
23.04%26.8M
Selling and administrative expenses
34.02%28.1M
106.48%10.51M
18.82%5.9M
1.72%5.69M
12.82%5.99M
15.60%20.97M
17.50%5.09M
10.08%4.97M
17.54%5.6M
17.24%5.31M
-General and administrative expense
34.02%28.1M
106.48%10.51M
18.82%5.9M
1.72%5.69M
12.82%5.99M
15.60%20.97M
17.50%5.09M
10.08%4.97M
17.54%5.6M
17.24%5.31M
Research and development costs
-19.21%66.43M
-6.94%18.41M
-24.46%14.96M
-18.53%17.24M
-26.34%15.83M
24.97%82.23M
16.99%19.78M
7.70%19.8M
59.62%21.16M
24.57%21.49M
Operating profit
8.42%-94.49M
-16.19%-28.89M
15.78%-20.86M
14.29%-22.92M
18.58%-21.82M
-23.54%-103.17M
-17.27%-24.87M
-9.88%-24.77M
-48.53%-26.75M
-23.14%-26.79M
Net non-operating interest income expense
-26.78%5.91M
-0.38%1.56M
1.42%1.93M
-60.20%868K
-35.99%1.54M
10.24%8.07M
-20.08%1.57M
2.64%1.9M
18.99%2.18M
44.78%2.41M
Non-operating interest income
-6.60%7.54M
55.39%2.44M
27.02%2.43M
-48.12%1.13M
-35.97%1.55M
9.84%8.07M
-20.11%1.57M
1.38%1.91M
18.91%2.18M
44.66%2.41M
Non-operating interest expense
18,077.78%1.64M
87,500.00%876K
8,150.00%495K
26,300.00%264K
0.00%1K
-74.29%9K
-50.00%1K
-79.31%6K
-50.00%1K
-50.00%1K
Other net income (expense)
-495.83%-190K
-122.88%-27K
-577.78%-86K
-21.05%-92K
225.00%15K
100.39%48K
100.95%118K
28.57%18K
-167.26%-76K
-163.16%-12K
Special income (charges)
----
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
----
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-495.83%-190K
-122.88%-27K
-577.78%-86K
-21.05%-92K
225.00%15K
-71.08%48K
490.00%118K
28.57%18K
-167.26%-76K
-163.16%-12K
Income before tax
6.61%-88.77M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
16.96%-20.26M
-7.48%-95.06M
26.74%-23.18M
-10.52%-22.85M
-53.42%-24.64M
-21.52%-24.39M
Income tax
-681K
0
0
0
-681K
0
0
0
0
0
Net income
7.33%-88.09M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.58M
-7.48%-95.06M
26.74%-23.18M
-10.52%-22.85M
-53.42%-24.64M
-21.52%-24.39M
Net income continuous Operations
7.33%-88.09M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.58M
-7.48%-95.06M
26.74%-23.18M
-10.52%-22.85M
-53.42%-24.64M
-21.52%-24.39M
Minority interest income
Net income attributable to the parent company
7.33%-88.09M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.58M
-7.48%-95.06M
26.74%-23.18M
-10.52%-22.85M
-53.42%-24.64M
-21.52%-24.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.33%-88.09M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.58M
-7.48%-95.06M
26.74%-23.18M
-10.52%-22.85M
-53.42%-24.64M
-21.52%-24.39M
Basic earnings per share
25.37%-1
18.18%-0.27
34.38%-0.21
22.86%-0.27
23.53%-0.26
19.28%-1.34
41.07%-0.33
17.95%-0.32
-9.37%-0.35
15.00%-0.34
Diluted earnings per share
25.37%-1
18.18%-0.27
34.38%-0.21
22.86%-0.27
23.53%-0.26
19.28%-1.34
41.07%-0.33
17.95%-0.32
-9.37%-0.35
15.00%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 105.00%41K420.00%26K0.00%5K0.00%5K0.00%5K-95.31%20K-86.49%5K-98.62%5K-16.67%5K-76.19%5K
Operating revenue 105.00%41K420.00%26K0.00%5K0.00%5K0.00%5K-95.31%20K-86.49%5K-98.62%5K-16.67%5K-76.19%5K
Cost of revenue
Gross profit
Operating expense -8.39%94.53M16.28%28.92M-15.78%20.86M-14.29%22.93M-18.58%21.82M22.94%103.19M17.09%24.87M8.17%24.77M48.50%26.75M23.04%26.8M
Selling and administrative expenses 34.02%28.1M106.48%10.51M18.82%5.9M1.72%5.69M12.82%5.99M15.60%20.97M17.50%5.09M10.08%4.97M17.54%5.6M17.24%5.31M
-General and administrative expense 34.02%28.1M106.48%10.51M18.82%5.9M1.72%5.69M12.82%5.99M15.60%20.97M17.50%5.09M10.08%4.97M17.54%5.6M17.24%5.31M
Research and development costs -19.21%66.43M-6.94%18.41M-24.46%14.96M-18.53%17.24M-26.34%15.83M24.97%82.23M16.99%19.78M7.70%19.8M59.62%21.16M24.57%21.49M
Operating profit 8.42%-94.49M-16.19%-28.89M15.78%-20.86M14.29%-22.92M18.58%-21.82M-23.54%-103.17M-17.27%-24.87M-9.88%-24.77M-48.53%-26.75M-23.14%-26.79M
Net non-operating interest income expense -26.78%5.91M-0.38%1.56M1.42%1.93M-60.20%868K-35.99%1.54M10.24%8.07M-20.08%1.57M2.64%1.9M18.99%2.18M44.78%2.41M
Non-operating interest income -6.60%7.54M55.39%2.44M27.02%2.43M-48.12%1.13M-35.97%1.55M9.84%8.07M-20.11%1.57M1.38%1.91M18.91%2.18M44.66%2.41M
Non-operating interest expense 18,077.78%1.64M87,500.00%876K8,150.00%495K26,300.00%264K0.00%1K-74.29%9K-50.00%1K-79.31%6K-50.00%1K-50.00%1K
Other net income (expense) -495.83%-190K-122.88%-27K-577.78%-86K-21.05%-92K225.00%15K100.39%48K100.95%118K28.57%18K-167.26%-76K-163.16%-12K
Special income (charges) ----------------------0----------------
-Less:Impairment of capital assets ----------------------0----------------
Other non- operating income (expenses) -495.83%-190K-122.88%-27K-577.78%-86K-21.05%-92K225.00%15K-71.08%48K490.00%118K28.57%18K-167.26%-76K-163.16%-12K
Income before tax 6.61%-88.77M-18.02%-27.36M16.77%-19.01M10.12%-22.15M16.96%-20.26M-7.48%-95.06M26.74%-23.18M-10.52%-22.85M-53.42%-24.64M-21.52%-24.39M
Income tax -681K000-681K00000
Net income 7.33%-88.09M-18.02%-27.36M16.77%-19.01M10.12%-22.15M19.75%-19.58M-7.48%-95.06M26.74%-23.18M-10.52%-22.85M-53.42%-24.64M-21.52%-24.39M
Net income continuous Operations 7.33%-88.09M-18.02%-27.36M16.77%-19.01M10.12%-22.15M19.75%-19.58M-7.48%-95.06M26.74%-23.18M-10.52%-22.85M-53.42%-24.64M-21.52%-24.39M
Minority interest income
Net income attributable to the parent company 7.33%-88.09M-18.02%-27.36M16.77%-19.01M10.12%-22.15M19.75%-19.58M-7.48%-95.06M26.74%-23.18M-10.52%-22.85M-53.42%-24.64M-21.52%-24.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.33%-88.09M-18.02%-27.36M16.77%-19.01M10.12%-22.15M19.75%-19.58M-7.48%-95.06M26.74%-23.18M-10.52%-22.85M-53.42%-24.64M-21.52%-24.39M
Basic earnings per share 25.37%-118.18%-0.2734.38%-0.2122.86%-0.2723.53%-0.2619.28%-1.3441.07%-0.3317.95%-0.32-9.37%-0.3515.00%-0.34
Diluted earnings per share 25.37%-118.18%-0.2734.38%-0.2122.86%-0.2723.53%-0.2619.28%-1.3441.07%-0.3317.95%-0.32-9.37%-0.3515.00%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More